Staphylococcus aureus counters organic acid anion-mediated inhibition of peptidoglycan cross-linking through robust alanine racemase activity

  1. Center for Staphylococcal Research, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5900, USA
  2. Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA
  3. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Center for Microbial Research (UCMR), Department of Molecular Biology, Umeå University, Umea SE-90187, Sweden

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a response from the authors (if available).

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Bavesh Kana
    University of the Witwatersrand, Johannesburg, South Africa
  • Senior Editor
    Bavesh Kana
    University of the Witwatersrand, Johannesburg, South Africa

Reviewer #1 (Public Review):

Summary:

The manuscript entitled "Staphylococcus aureus counters organic acid anion-mediated inhibition of peptidoglycan cross-linking through robust alanine racemase activity" by Panda, S et al. reports an extensive biochemical analysis of the result from a Tn screen that identified alr1 as being required for acetic acid tolerance. In the end, they demonstrate that reduced D-Ala pools in the ∆alr1 mutant lead to a drastic reduction in D-Ala-D-Ala dipeptide. They show that this is due to the ability of organic acid anions to limit the D-Ala-D-Ala ligase enzyme Ddl. They demonstrate that:

(1) Acetate exposure in the ∆alr1 results in reduced D-Ala-D-Ala dipeptide, but not the monomers.

(2) Acetate can bind to purified Ddl in vitro.

(3) This binding results in reduced enzyme activity.

(4) Other organic acid anions such as lactate, proprionate, and itaconitate can also inhibit Ddl.

The experiments are clearly described and logically laid out. I have only a few minor comments to add.

Strengths:

The most significant strength is the exceptional experimental data that supports the authors' hypotheses.

Weaknesses:

Only minor weaknesses were identified by this reviewer.

(1) Which allele is alr1, the one upstream of MazEF or the one in the Lysine biosynthetic operon?

(2) Figure 3B. Where does the C3N2 species come from in the WT and why is it absent in the mutants? It is about 25% of the total dipeptide pool.

(3) Figure 3D could perhaps be omitted. I understand that the authors attained statistical significance in the fitness defect, but biologically this difference is very minor. One would have to look at the isotopomer distribution in the Dat overexpressing strain to make sure that increased flux actually occurred since there are other means of affecting activity (e.g. allosteric modulators).

(4) In Figure 4A, why is the complete subunit UDP-NAM-AEKAA increasing in each strain upon acetate challenge if there was such a stark reduction in D-Ala-D-Ala, particularly in the ∆alr1 mutant? For that matter, why are the levels of UDP-NAM-AEKAA in the ∆alr1 mutant identical to that of WT with/out acetate?

(5) Figure 4B. Is there no significant difference between ddl and murF transcripts between WT and ∆alr1 under acetate stress? This comparison was not labeled if the tests were done.

(6) Although tricky, it is possible to measure intracellular acetate. It might be of interest to know where in the Ddl inhibition curve the cells actually are.

Reviewer #2 (Public Review):

Summary:

In this manuscript, using Staphylococcus aureus as a model organism, Panda et al. aim to understand how organic acids inhibit bacterial growth. Through careful characterization and interdisciplinary collaboration, the authors present valuable evidence that acetic acid specifically inhibits the activity of Ddl enzyme that converts 2 D-alanine amino acids into D-ala-D-ala dipeptide, which is then used to generate the stem pentapeptide of peptidoglycan (PG) precursors in the cytoplasm. Thus, a high concentration of acetic acid weakens the cell wall by limiting PG-crosslinking (which requires a D-ala portion). However, S. aureus maintains a high intracellular D-ala concentration to circumvent acetate-mediated growth inhibition.

Strengths:

The authors utilized a well-established transposon mutant library to screen for mutants that struggle to grow in the presence of acetic acid. This screen allowed authors to identify that a strain lacking intact alr1, which encodes for alanine racemase (converts L-ala to D-ala), is unable to grow well in the presence of acetic acid. This phenotype is rescued by the addition of external D-ala. Next, the authors rule out the contribution of other pathways that could lead to the production of D-ala in the cell. Finally, by analyzing D-ala and D-ala-D-ala concentrations, as well as muropeptide intermediates accumulation in different mutants, the authors pinpoint Ddl as the specific target of acetic acid. In fact, the synthetic overexpression of ddl alone overcomes the toxic effects of acetic acid. Using genetics, biochemistry, and structural biology, the authors show that Ddl activity is specifically inhibited by acetic acid and likely by other biologically relevant organic acids. Interestingly, this mechanism is different from what has been reported for other organisms such as Escherichia coli (where methionine synthesis is affected). It remains to be seen if this mechanism is conserved in other organisms that are more closely related to S. aureus, such as Clostridioides difficile and Enterococcus faecalis.

Weaknesses:

Although the authors have conclusively shown that Ddl is the target of acetic acid, it appears that the acetic acid concentration used in the experiments may not truly reflect the concentration range S. aureus would experience in its environment. Moreover, Ddl is only significantly inhibited at a very high acetate concentration (>400 mM). Thus, additional experiments showing growth phenotypes at lower organic acid concentrations may be beneficial. Another aspect not adequately discussed is the presence of D-ala in the gut environment, which may be protective against acetate toxicity based on the model provided.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation